Decellularized Adipose Matrix Rejuvenates Photoaged Skin through Immune Microenvironment Modulation
BME Frontiers · 2025-01 · 6
DOI: 10.34133/bmef.0166 ↗Kurz gefasst
Fachartikel in der Zeitschrift BME Frontiers, online erschienen am 04.08.2025. Verfasst von Jialiang Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
This study aims to explore the therapeutic potential of decellularized adipose matrix (DAM) in rejuvenating photoaged skin by modulating the immune microenvironment. Impact Statement: DAM effectively induces M1 to M2 macrophage polarization and rescues the function of photoaged fibroblasts through paracrine mechanisms, providing a novel strategy for skin antiaging through immune microenvironment remodeling.
Introduction
Photoaging, triggered by prolonged ultraviolet exposure, is marked by the depletion of skin structural elements and a persistent inflammatory environment. Current clinical interventions primarily target structural defects, while immune modulation remains underexplored. Therefore, developing biomaterials with both extracellular matrix (ECM) replenishment and immune regulatory functions is crucial for skin regeneration.
Methods
A photoaged mouse model was established using ultraviolet B irradiation to validate the inflammatory microenvironment. DAM was prepared via physicochemical decellularization and assessed in vitro for its effects on macrophage polarization and macrophage-fibroblast cross-talk. A DAM-functionalized hyaluronic acid (HA/DAM) hydrogel was developed and evaluated for its effects on skin rejuvenation via subcutaneous injection.
Results
In vitro experiments demonstrated that DAM substantially promoted M2 macrophage polarization, and M2-macrophage-conditioned medium further improved fibroblast functions, including oxidative stress resistance, migration, and ECM synthesis. In vivo, HA/DAM hydrogel not only increased dermal thickness and collagen density but also restructured the immune microenvironment through M2 macrophage polarization.
Conclusion
DAM offers a novel therapeutic approach for skin rejuvenation by modulating the immune microenvironment, demonstrating notable clinical potential.
Autor:innen und Institutionen
- Department of Stomatology, Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
- Department of Oral and Cranio-Maxillofacial Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomato…
- Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
ORCID-Profile: Kaili Lin
Förderung
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- National Natural Science Foundation of China
Zitieren
APA
Zhou, J., Jiang, S., Wang, L., Lin, K., Wu, J., Gui, H., & Gao, Z. (2025). Decellularized Adipose Matrix Rejuvenates Photoaged Skin through Immune Microenvironment Modulation. BME Frontiers, 6. https://doi.org/10.34133/bmef.0166
Vancouver
Zhou J, Jiang S, Wang L, Lin K, Wu J, Gui H, et al. Decellularized Adipose Matrix Rejuvenates Photoaged Skin through Immune Microenvironment Modulation. BME Frontiers. 2025;6. doi:10.34133/bmef.0166
BibTeX
@article{Zhou2025,
author = {Zhou, Jialiang and Jiang, Shengjie and Wang, Liyun and Lin, Kaili and Wu, Jianyong and Gui, Haijun and Gao, Zhen},
title = {Decellularized Adipose Matrix Rejuvenates Photoaged Skin through Immune Microenvironment Modulation},
journal = {BME Frontiers},
year = {2025},
volume = {6},
doi = {10.34133/bmef.0166}
}
EUVIMED